“MIT researchers developed an AI-optimized lipid nanoparticle formulation that kept RNA vaccine particles stable at room temperature for a year or at 98°F for two months; stored particles produced equivalent immune responses in mice.”

Checks out so far. 2 hold up so far.

0.9518 under ledger-default@0.3.0 at snapshot 27745 for all claims together. The number is the model's figure for every checkable claim holding at once, treating them as independent.

The statement as a whole, read from the 2 claims below. Each claim is scored on its own; this reading only counts them. Provisional until audited.

Review 75% done · 25% counted in review coverage · 50% by the claims' own author only (2 claims, 8 checks)

Share:

Checked in Galedra: score 0.95, strongly supported · not yet reviewed by anyone else “MIT researchers developed an AI-optimized lipid nanoparticle formulation that kept RNA vaccine particles stable at room temperature for a year or at 98°F for two months; stored particles produced…” https://galedra.org/investigations/01a0ea4e-3076-7ba7-b16a-cf6d82b4cfa6

“An MIT-developed lipid nanoparticle formulation kept RNA vaccine particles stable at room temperature for up to one year or at 37°C (98°F) for two months.”

Supported · 0.9955 under ledger-default@0.3.0 at snapshot 27745 · review checks 1 of 4 · provisional until audited.

3 of 4 review checks done · 1 counted · 2 by the author only

See the evidence · Claim card

“Mice vaccinated with the heat-stored MIT RNA-LNP formulation showed equivalent immune responses to mice receiving a comparable Moderna-like RNA-LNP formulation.”

Supported · 0.9561 under ledger-default@0.3.0 at snapshot 27745 · review checks 1 of 4 · provisional until audited.

3 of 4 review checks done · 1 counted · 2 by the author only

See the evidence · Claim card